Oncolytics Biotech Reports Data in Colorectal Cancer Study
By Karen Roman Oncolytics Biotech Inc. (Nasdaq: ONCY) said it has new data showing the use of pelareorep in metastatic colorectal cancer has a 19.5-month median...
Video Highlights from IPO Edge Bootcamp at Nasdaq
IPO Edge is pleased to provide video highlights of the IPO Edge Bootcamp, which was...
Cross Border Listings Panel from IPO Edge Bootcamp at Nasdaq
IPO Edge is pleased to provide video highlights of the IPO Edge Bootcamp, which was...
Investor Engagement in Private vs. Public Markets Panel From IPO Edge Bootcamp at Nasdaq
IPO Edge is pleased to provide video highlights of the IPO Edge Bootcamp, which was...
Three CFOs on IPOs Panel from IPO Edge Bootcamp at Nasdaq
IPO Edge is pleased to provide video highlights of the IPO Edge Bootcamp, which was...
Readiness and the Road to IPO Panel from IPO Edge Bootcamp at Nasdaq
IPO Edge is pleased to provide video highlights of the IPO Edge Bootcamp, which was...
Capital Markets Update Panel from IPO Edge Bootcamp at Nasdaq
IPO Edge is pleased to provide video highlights of the IPO Edge Bootcamp, which was...
HIGHLIGHTS: Bet on Global Gaming: Fireside with CEOs of Golden Matrix Group, MeridianBet
IPO Edge and the Palm Beach Hedge Fund Association hosted a fireside chat with Golden Matrix Group...
